BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 30661859)

  • 1. The Informant AD8 Can Discriminate Patients with Dementia From Healthy Control Participants in an Asian Older Cohort.
    Kan CN; Zhang L; Cheng CY; Wong TY; Venketasubramanian N; Chen CL; Xu X
    J Am Med Dir Assoc; 2019 Jun; 20(6):775-779. PubMed ID: 30661859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reliability and validity of the informant AD8 by comparison with a series of cognitive assessment tools in primary healthcare.
    Shaik MA; Xu X; Chan QL; Hui RJ; Chong SS; Chen CL; Dong Y
    Int Psychogeriatr; 2016 Mar; 28(3):443-52. PubMed ID: 26489991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The informant AD8 is superior to participant AD8 in detecting cognitive impairment in a memory clinic setting.
    Dong Y; Pang WS; Lim LB; Yang YH; Morris JC; Hilal S; Venketasubramanian N; Chen CL
    J Alzheimers Dis; 2013; 35(1):159-68. PubMed ID: 23380993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of the informant AD8 as a dementia case finding instrument in primary healthcare.
    Chan QL; Xu X; Shaik MA; Chong SS; Hui RJ; Chen CL; Dong Y
    J Alzheimers Dis; 2016; 49(1):121-7. PubMed ID: 26444776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informant-based dementia screening in a population-based sample of African Americans.
    Malmstrom TK; Miller DK; Coats MA; Jackson P; Miller JP; Morris JC
    Alzheimer Dis Assoc Disord; 2009; 23(2):117-23. PubMed ID: 19484913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders.
    Liew TM; Feng L; Gao Q; Ng TP; Yap P
    J Am Med Dir Assoc; 2015 Feb; 16(2):144-8. PubMed ID: 25282632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Combined Utility of a Brief Functional Measure and Performance-Based Screening Test for Case Finding of Cognitive Impairment in Primary Healthcare.
    Chan QL; Shaik MA; Xu J; Xu X; Chen CL; Dong Y
    J Am Med Dir Assoc; 2016 Apr; 17(4):372.e9-11. PubMed ID: 26857297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AD8: a brief informant interview to detect dementia.
    Galvin JE; Roe CM; Powlishta KK; Coats MA; Muich SJ; Grant E; Miller JP; Storandt M; Morris JC
    Neurology; 2005 Aug; 65(4):559-64. PubMed ID: 16116116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AD8 (Dementia Screening Interview) is a valid and reliable screening scale not only for dementia but also for mild cognitive impairment in the Turkish geriatric outpatients.
    Usarel C; Dokuzlar O; Aydin AE; Soysal P; Isik AT
    Int Psychogeriatr; 2019 Feb; 31(2):223-229. PubMed ID: 29923472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of cognitive impairment using self-rated AD8 and informant-reported AD8.
    Chio OI; Yip PK; Liu YC; Chen LH; Wang PC; Tsai TH; Tang SH
    J Formos Med Assoc; 2018 Jan; 117(1):42-47. PubMed ID: 28336001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Montreal Cognitive Assessment and the Mini-Mental State Examination in detecting multi-domain mild cognitive impairment in a Chinese sub-sample drawn from a population-based study.
    Dong Y; Yean Lee W; Hilal S; Saini M; Wong TY; Chen CL; Venketasubramanian N; Ikram MK
    Int Psychogeriatr; 2013 Nov; 25(11):1831-8. PubMed ID: 23870281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
    Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
    Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cognitive impairment in older adults: combining brief informant and performance measures.
    Galvin JE; Roe CM; Morris JC
    Arch Neurol; 2007 May; 64(5):718-24. PubMed ID: 17502471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity and reliability of the Korean version of the AD8 informant interview (K-AD8) in dementia.
    Ryu HJ; Kim HJ; Han SH
    Alzheimer Dis Assoc Disord; 2009; 23(4):371-6. PubMed ID: 19561437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Chinese version of informant AD8 for mild cognitive impairment and dementia screening in community-dwelling older adults.
    Wang Y; Liu T; Cai Y; Wu Y; Nie Y; Kuang W; Qiu P; Wan Y
    Public Health Nurs; 2023 Mar; 40(2):258-265. PubMed ID: 36633577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the diagnostic accuracy of the Mini-Cog and AD8 in identifying cognitive impairment in a geriatric health screening population in China.
    Shang Y; Guo Y; Wei C; Zhou B; Xie H
    Appl Neuropsychol Adult; 2024; 31(1):69-76. PubMed ID: 34672895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the Montreal Cognitive Assessment and Alzheimer's Disease-8 as cognitive screening measures in Parkinson's disease.
    Brown DS; Bernstein IH; McClintock SM; Munro Cullum C; Dewey RB; Husain M; Lacritz LH
    Int J Geriatr Psychiatry; 2016 Mar; 31(3):264-72. PubMed ID: 26177715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normative Data of Mini-Mental State Examination, Montreal Cognitive Assessment, and Alzheimer's Disease Assessment Scale-Cognitive Subscale of Community-Dwelling Older Adults in Taiwan.
    Wei YC; Chen CK; Lin C; Chen PY; Hsu PC; Lin CP; Shyu YC; Huang WY
    Dement Geriatr Cogn Disord; 2022; 51(4):365-376. PubMed ID: 35820405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reliability and validity of the Japanese version of the AD8].
    Meguro K; Kasai M; Nakamura K;
    Nihon Ronen Igakkai Zasshi; 2015; 52(1):61-70. PubMed ID: 25786630
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.